Clinical trial
Clinical Trial to Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol in Comparison to the Single Components and Placebo in Adults With Exercise Induced Asthma Randomised, Placebo-controlled, Double-blind, Crossover, Multicentre Study
NCT00777348 is registered in ClinicalTrials.gov with MEDA Pharma GmbH & Co. KG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Trial to Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol in Comparison to the Single Components and Placebo in Adults With Exercise Induced Asthma Randomised, Placebo-controlled, Double-blind, Crossover, Multicentre Study
- Lead sponsor
- MEDA Pharma GmbH & Co. KG
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2007
- Completion date
- October 31, 2008
- Enrollment
- 62 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.